15953144

Source:http://linkedlifedata.com/resource/pubmed/id/15953144

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0018916, umls-concept:C0087111, umls-concept:C0231330
pubmed:issue	2
pubmed:dateCreated	2005-6-14
pubmed:abstractText	Hemangiomas of infancy are the most common tumors of childhood. They are clinically heterogeneous and as such require individualized treatment plans. Although there are no Food and Drug Administration (FDA)-approved agents for treatment of hemangiomas of infancy, there are many widely used therapeutic options available. This review highlights the treatments currently in use and the factors that direct treatment.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9700070
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:issn	1396-0296
pubmed:author	pubmed-author:BarrioVictoria RVR, pubmed-author:DroletBeth ABA
pubmed:issnType	Print
pubmed:volume	18
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	151-9
pubmed:dateRevised	2005-11-16
pubmed:meshHeading	pubmed-meshheading:15953144-Hemangioma, pubmed-meshheading:15953144-Humans, pubmed-meshheading:15953144-Infant, Newborn, pubmed-meshheading:15953144-Neoplasms, Vascular Tissue
pubmed:articleTitle	Treatment of hemangiomas of infancy.
pubmed:affiliation	Department of Dermatology, Medical College of Wisconsin, Milwaukee, WI, USA.
pubmed:publicationType	Journal Article, Review